Curious to see the emissions of the organizations you buy from or invest in?
Book a demo for a pilot project
Hengrui Pharma (Jiangsu Hengrui Medicine Co., Ltd.), a leading force in pharmaceutical preparation manufacturing, is headquartered in China. Established in 1970, Hengrui has evolved into a globally recognised innovator in the healthcare sector. They specialise in research, development, manufacturing, and commercialisation of a diverse range of medicines.
Their portfolio boasts a strong presence in oncology, anaesthesia, and cardiovascular diseases, with a growing footprint in autoimmune and metabolic disorders. Hengrui Pharma is distinguished by its robust R&D pipeline and a commitment to delivering high-quality, impactful therapies to patients worldwide. As a prominent player, Hengrui consistently strives to advance medical science and improve human health.
31
DitchCarbon score
-11 vs industry average
Hengrui Pharma’s score of 31 is lower than 43% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Part of the Sustainability team at Hengrui Pharma?
- Control how your company's emission story is told
- Respond to customers efficiently
- See who's viewing your profile
Industry Intensity
Very High
Pharmaceutical Preparation Manufacturing is among the most carbon-intensive industries
Industry performance
0.243
02025
The Pharmaceutical Preparation Manufacturing industry has increased its overall emissions by 132% since 0
Emissions trajectory 2020 – 2028
202020212022202320242025202620272028
Reported emissions
Scope 1
•••kg CO₂e
Scope 2
•••kg CO₂e
Scope 3
•••kg CO₂e
Total reported
•••kg CO₂e
Scope 3 accounts for ••• of total emissions.
Hengrui Pharma's reported carbon emissions
Hengrui Pharma, a Pharmaceutical Preparation Manufacturing company based in CN, reported total carbon emissions of approximately 1.08 billion kg CO2e in 2025. This figure comprises 54.87 million kg CO2e from Scope 1 emissions, 270.56 million kg CO2e from Scope 2 emissions, and 756.66 million kg CO2e from Scope 3 emissions.
In previous years, Hengrui Pharma's emissions were as follows:
- 2024: Total emissions were approximately 257.90 million kg CO2e, including 8.52 million kg CO2e from Scope 1 and 249.38 million kg CO2e from Scope 2. Scope 3 data was not disclosed for this year.
- 2023: Total emissions were approximately 208.28 million kg CO2e, with 4.90 million kg CO2e from Scope 1 and 203.38 million kg CO2e from Scope 2. Scope 3 data was not disclosed.
- 2022: Scope 1 emissions were approximately 5.99 million kg CO2e, and Scope 2 emissions were approximately 197.52 million kg CO2e.
- 2021: Scope 1 emissions were approximately 8.84 million kg CO2e, and Scope 2 emissions were approximately 235.22 million kg CO2e.
Hengrui Pharma is committed to exploring pathways towards carbon neutrality. The company aims to reduce carbon emissions during operations, specifically for Scope 1 and Scope 2, between 2023 and 2025.
Assessing Hengrui Pharma as a supplier or portfolio company?
- See verified emissions data for over 2 million organizations
- View emissions forecasts for Hengrui Pharma and the organizations you buy from or invest in
- Get PCAF data quality (DQ) scores, including for private organizations
Hengrui Pharma’s Climate Goals (2030 & 2050)
2025
Near-zero scope 1 & 2
Target to achieve near-zero emissions for direct operations and purchased energy
On track94%
2030
62% reduction in total GHG
Vs 2019 baseline. Validated by SBTi. Includes full supply chain.
At risk48%
2040
50% reduction in Scope 3 intensity
Across purchased goods and services and logistics.
Behind target22%
Showing SBTi-validated targets only. Sign up or sign in to see all disclosed climate targets.
Scope 3 top emissions categories
No scope 3 category breakdown has been disclosed yet.
Climate initiatives
Science Based Targets Initiative
See details
Not active
Carbon Disclosure Project
See details
Not active
The Climate Pledge
See details
Not active
UN Global Compact Climate Champions initiative
See details
Not active
RE 100
See details
Not active
Climate Action 100
See details
Not active
Emissions comparison with industry peers
View similar organisationsCompanyCountryIndustryLast updatedScoreDetails
Hengrui Pharma11 months ago
31
Need this data for financed emissions?
PCAF scored Scope 1, 2 and 3 for 2M+ organizations, including private ones.
Usage policy
You’re welcome to quote or reference data from this page, but please include a visible link back to this URL. Bulk collection, resale, or redistribution of data from multiple profiles is not permitted.
See our License Agreement for more details.
Where does DitchCarbondata come from?
Discover our data-driven methodology for measuring corporate climate action and benchmarking against industry peers
Learn more